Who was studied, and how
Two numbers in the abstract
Where each one falls
Only readable comparisons vote
Where it lands on the map
What it changes
Among 5 other studies
830people in the The Impact of Dietary Management Applet for Weight Reduction in Obese Heart Failure Patients trial, from 2024
241of them with cardiovascular disease, in this paper
The trial randomly assignedassigned by chance
liraglutide 1.8 mg once daily
matching placebo
No clear effect on LVEF−0.80
Probably raised heart rate+7.00
randomisedthe abstract, start to end
… difference (95% confidence interval) was -0.8% (-2.1, 0.5; P = 0.24).
… with liraglutide [mean difference: 7 b.p.m.
← favours treatmentfavours comparator →
could be chanceChange in LVEFliraglutide 1.8 mg once daily vs matching placebo
−0.8−2.10 to 0.50
Heart rateliraglutide 1.8 mg once daily vs matching placebo
75.00–9.00
GLP-1 receptor agonistsCardiac & vascular functionAdverse events & safety
GLP-1 receptor agonists × cardiac & vascular functionhelps?mixed
unlikelylikely
0.500.50 without it
← favours comparatorfavours treatment →
1 / 7